Raymond James Financial
SANA icon

Raymond James Financial’s Sana Biotechnology SANA Stock Holding History

Raymond James Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.3K Sell
16,407
-20,000
-55% -$64.4K ﹤0.01% 5244
2026
Q1 		$105K Sell
36,407
-2,866
-7% -$11.3K ﹤0.01% 5028
2025
Q4 		$160K Buy
+39,273
New +$176K ﹤0.01% 4839
2025
Q3 		– Sell
-477
Closed -$1.3K – 6422
2025
Q2 		$1.3K Buy
+477
New +$984 ﹤0.01% 6513

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Raymond James Financial's SANA Position: Q2 2026 in Review

Raymond James Financial reduced its Sana Biotechnology (SANA) stake by 55% in Q2 2026, selling an estimated $64.4K and leaving 16,407 shares worth $57.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5244.

Raymond James Financial first reported a position in SANA in Q2 2025 and has held it in 4 quarters since. The position peaked at $160K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Raymond James Financial held 16,407 shares of Sana Biotechnology worth $57.3K as of Q2 2026.
  • Raymond James Financial sold 20,000 Sana Biotechnology shares in Q2 2026, an estimated $64.4K.
  • Sana Biotechnology made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5244 holding.
  • Raymond James Financial first reported a position in Sana Biotechnology in Q2 2025 and has held it in 4 quarters since.
  • Raymond James Financial's Sana Biotechnology position peaked at $160K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.